Australian expert: China's chikungunya outbreak poses low risk to Australia

China is contending with a mosquito-borne virus that has already infected more than 10,000 people across a dozen cities, with roughly 3,000 new cases emerging in the past week alone. The illness, chikungunya, has now crossed into Taiwan after spreading through the densely populated regions of southern China. Yet according to Nick Coatsworth, an Australian infectious disease specialist, Australians need not lose sleep over it.

Chikungunya arrives with fever, severe joint pain, a rash, and exhaustion. Though deaths are uncommon, the virus can leave people struggling with symptoms for weeks or even months afterward. The name itself, borrowed from Tanzanian language, translates to "to double over"—a nod to the joint pain that defines the illness. It spreads through mosquitoes, which means controlling it depends entirely on managing the insects and the people they bite.

Coatsworth's assessment hinges on a crucial difference between China's situation and Australia's. In densely packed Chinese cities, the virus finds an ideal breeding ground: humans serve as amplifying hosts, meaning the pathogen circulates between people and mosquitoes in a tight loop that becomes nearly impossible to interrupt. Australia, by contrast, already contends with a similar virus called Ross River, which produces comparable symptoms and has never spiraled into the kind of outbreak China now faces. Returned travellers have brought chikungunya to Australian shores before, Coatsworth noted, yet it has never taken hold.

When asked whether chikungunya might become another global pandemic like COVID-19, Coatsworth was direct: this is not a novel threat. The virus has circulated for decades across Asia, Africa, and the Americas in periodic outbreaks. It lacks the transmissibility and novelty that made the coronavirus so catastrophic. "I don't think it's going to be something like Covid that's going to spread around the world in a pandemic sort of fashion," he said during an appearance on 2GB radio.

Yet Coatsworth's real worry lies elsewhere. He expressed deep unease about China's willingness to share information about emerging diseases. The Morrison Government spent considerable effort trying to understand what happened in Wuhan during the early days of COVID-19 and ultimately got nowhere. The subsequent Albanese Government, he suggested, abandoned the effort entirely. That opacity troubles him far more than the virus itself. If a genuinely novel pathogen emerges in China, the world may not learn about it quickly enough to respond.

Meanwhile, China has responded to the outbreak with measures that echo its COVID-era playbook: quarantines, mass surveillance, and mandatory reporting by pharmacies of customers buying fever medications. The US Centers for Disease Control has issued a Level 2 travel advisory for Guangdong Province, recommending extra precautions for those heading there. Taiwan confirmed its first imported case on Friday—a woman who had recently returned from Foshan, the epicentre of the outbreak in Guangdong.

For Australia, the calculus remains straightforward. The country has the infrastructure, the experience with similar viruses, and the mosquito ecology to prevent chikungunya from establishing itself. But the broader lesson—about disease surveillance, transparency, and the speed at which information travels in a connected world—lingers as the more unsettling question.